nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—LDLRAP1—atherosclerosis	0.0329	0.049	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—PLTP—atherosclerosis	0.0309	0.046	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—ABCG8—atherosclerosis	0.0268	0.0399	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—connective tissue—atherosclerosis	0.0248	0.315	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOA4—atherosclerosis	0.0229	0.0341	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—cardiovascular system—atherosclerosis	0.0216	0.274	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—ABCG1—atherosclerosis	0.0212	0.0315	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—LCAT—atherosclerosis	0.0199	0.0297	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—FABP4—atherosclerosis	0.0199	0.0297	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOA2—atherosclerosis	0.0197	0.0294	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOA4—atherosclerosis	0.0195	0.0291	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—adipose tissue—atherosclerosis	0.019	0.242	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOA2—atherosclerosis	0.0168	0.0251	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—ABCG5—atherosclerosis	0.0166	0.0248	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—LPA—atherosclerosis	0.016	0.0239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOA5—atherosclerosis	0.0154	0.0229	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOC3—atherosclerosis	0.0148	0.0221	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—LDLR—atherosclerosis	0.0148	0.022	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—liver—atherosclerosis	0.0133	0.169	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—LIPC—atherosclerosis	0.0127	0.019	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOC3—atherosclerosis	0.0127	0.0189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—LDLR—atherosclerosis	0.0126	0.0188	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—CETP—atherosclerosis	0.0123	0.0183	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—SCARB1—atherosclerosis	0.0118	0.0175	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOA4—atherosclerosis	0.0117	0.0174	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOA2—atherosclerosis	0.0101	0.015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—ABCA1—atherosclerosis	0.00991	0.0148	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOB—atherosclerosis	0.00955	0.0142	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—LPL—atherosclerosis	0.00912	0.0136	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOB—atherosclerosis	0.00815	0.0121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—LPL—atherosclerosis	0.00778	0.0116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOE—atherosclerosis	0.00764	0.0114	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOC3—atherosclerosis	0.00758	0.0113	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOA1—atherosclerosis	0.00755	0.0113	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—LDLR—atherosclerosis	0.00753	0.0112	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOE—atherosclerosis	0.00652	0.00971	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—CAV1—atherosclerosis	0.00646	0.00963	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOA1—atherosclerosis	0.00645	0.0096	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal discomfort—Lovastatin—atherosclerosis	0.0062	0.0248	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Simvastatin—atherosclerosis	0.0058	0.0232	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Rosuvastatin—atherosclerosis	0.00524	0.0209	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—ALB—atherosclerosis	0.00511	0.00761	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOB—atherosclerosis	0.00487	0.00726	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.0047	0.007	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—LPL—atherosclerosis	0.00465	0.00694	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Lovastatin—atherosclerosis	0.00444	0.0177	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Ezetimibe—atherosclerosis	0.00442	0.0177	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00441	0.00658	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Ezetimibe—atherosclerosis	0.00436	0.0174	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00426	0.017	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Simvastatin—atherosclerosis	0.00415	0.0166	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOE—atherosclerosis	0.0039	0.00581	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Niacin—atherosclerosis	0.00387	0.0155	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOA1—atherosclerosis	0.00386	0.00575	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00383	0.0057	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00383	0.0057	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Rosuvastatin—atherosclerosis	0.00382	0.0153	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Niacin—atherosclerosis	0.00381	0.0152	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Pravastatin—atherosclerosis	0.00375	0.015	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00355	0.0142	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Ezetimibe—atherosclerosis	0.00354	0.0141	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Rosuvastatin—atherosclerosis	0.00343	0.0137	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Lovastatin—atherosclerosis	0.00324	0.0129	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Lovastatin—atherosclerosis	0.0032	0.0128	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Ezetimibe—atherosclerosis	0.00318	0.0127	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Lovastatin—atherosclerosis	0.00317	0.0127	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Ezetimibe—atherosclerosis	0.00314	0.0125	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00311	0.0124	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Rosuvastatin—atherosclerosis	0.00311	0.0124	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Ezetimibe—atherosclerosis	0.00311	0.0124	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Simvastatin—atherosclerosis	0.00303	0.0121	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00303	0.00451	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00301	0.012	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Simvastatin—atherosclerosis	0.00299	0.012	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00297	0.0119	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Rosuvastatin—atherosclerosis	0.00297	0.0119	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Simvastatin—atherosclerosis	0.00297	0.0119	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00295	0.0118	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Lovastatin—atherosclerosis	0.00291	0.0116	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Rosuvastatin—atherosclerosis	0.00287	0.0115	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Ezetimibe—atherosclerosis	0.00285	0.0114	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.00284	0.00424	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.00284	0.00424	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00281	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00279	0.00416	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Niacin—atherosclerosis	0.00278	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Niacin—atherosclerosis	0.00275	0.011	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00274	0.00409	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Pravastatin—atherosclerosis	0.00274	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Rosuvastatin—atherosclerosis	0.00274	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Rosuvastatin—atherosclerosis	0.00273	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Niacin—atherosclerosis	0.00273	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Simvastatin—atherosclerosis	0.00272	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Rosuvastatin—atherosclerosis	0.00272	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Pravastatin—atherosclerosis	0.0027	0.0108	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Pravastatin—atherosclerosis	0.00268	0.0107	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Lovastatin—atherosclerosis	0.00264	0.0105	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Ezetimibe—atherosclerosis	0.00259	0.0103	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Niacin—atherosclerosis	0.00258	0.0103	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Rosuvastatin—atherosclerosis	0.00258	0.0103	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00254	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.00254	0.00378	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Lovastatin—atherosclerosis	0.00252	0.0101	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Niacin—atherosclerosis	0.0025	0.00998	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Simvastatin—atherosclerosis	0.00247	0.00987	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Ezetimibe—atherosclerosis	0.00247	0.00987	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Pravastatin—atherosclerosis	0.00246	0.00983	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Lovastatin—atherosclerosis	0.00243	0.00972	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.0024	0.00358	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.0024	0.00358	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.0024	0.00358	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.0024	0.00358	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Ezetimibe—atherosclerosis	0.00239	0.00953	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00237	0.00354	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Simvastatin—atherosclerosis	0.00235	0.00941	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Lovastatin—atherosclerosis	0.00234	0.00935	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Lovastatin—atherosclerosis	0.00232	0.00927	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Lovastatin—atherosclerosis	0.00232	0.00926	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Lovastatin—atherosclerosis	0.0023	0.00921	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Ezetimibe—atherosclerosis	0.00229	0.00917	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00229	0.00342	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Simvastatin—atherosclerosis	0.00227	0.00909	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Ezetimibe—atherosclerosis	0.00227	0.00909	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Ezetimibe—atherosclerosis	0.00227	0.00908	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Niacin—atherosclerosis	0.00227	0.00906	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Ezetimibe—atherosclerosis	0.00226	0.00903	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Pravastatin—atherosclerosis	0.00223	0.00892	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.0022	0.00328	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Simvastatin—atherosclerosis	0.00219	0.00874	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Lovastatin—atherosclerosis	0.00218	0.00873	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Simvastatin—atherosclerosis	0.00217	0.00867	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Simvastatin—atherosclerosis	0.00217	0.00866	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Niacin—atherosclerosis	0.00216	0.00864	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Simvastatin—atherosclerosis	0.00215	0.00861	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Ezetimibe—atherosclerosis	0.00214	0.00856	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Pravastatin—atherosclerosis	0.00213	0.00851	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.00212	0.00315	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LDLRAP1—atherosclerosis	0.00209	0.00312	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Niacin—atherosclerosis	0.00209	0.00835	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Pravastatin—atherosclerosis	0.00206	0.00822	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00204	0.00305	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Simvastatin—atherosclerosis	0.00204	0.00817	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Niacin—atherosclerosis	0.00201	0.00803	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Niacin—atherosclerosis	0.00199	0.00796	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Niacin—atherosclerosis	0.00199	0.00795	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Niacin—atherosclerosis	0.00198	0.00791	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Pravastatin—atherosclerosis	0.00198	0.0079	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PLTP—atherosclerosis	0.00197	0.00293	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Pravastatin—atherosclerosis	0.00196	0.00784	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Pravastatin—atherosclerosis	0.00196	0.00783	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Pravastatin—atherosclerosis	0.00195	0.00779	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Niacin—atherosclerosis	0.00188	0.0075	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Pravastatin—atherosclerosis	0.00185	0.00738	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00182	0.00271	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.00181	0.0027	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.0018	0.00268	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.00176	0.00262	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LTA4H—atherosclerosis	0.0017	0.00254	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCG8—atherosclerosis	0.0017	0.00254	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00168	0.00251	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.00159	0.00237	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOA4—atherosclerosis	0.00148	0.00221	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.00142	0.00211	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCG1—atherosclerosis	0.00135	0.00201	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HRH1—atherosclerosis	0.00133	0.00197	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOA2—atherosclerosis	0.00128	0.0019	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—FABP4—atherosclerosis	0.00127	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LCAT—atherosclerosis	0.00127	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOA4—atherosclerosis	0.00124	0.00185	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP7A1—atherosclerosis	0.00122	0.00182	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—BGN—atherosclerosis	0.00118	0.00176	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.00116	0.00173	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP27A1—atherosclerosis	0.00113	0.00168	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.00111	0.00166	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.00108	0.00162	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PLA2G2A—atherosclerosis	0.00107	0.0016	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOA2—atherosclerosis	0.00107	0.0016	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALOX5AP—atherosclerosis	0.00107	0.0016	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALOX15—atherosclerosis	0.00107	0.0016	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCG5—atherosclerosis	0.00106	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.00106	0.00157	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOA4—atherosclerosis	0.00104	0.00155	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CST3—atherosclerosis	0.00103	0.00153	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LPA—atherosclerosis	0.00102	0.00152	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—BGN—atherosclerosis	0.000989	0.00147	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000982	0.00146	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOA5—atherosclerosis	0.000979	0.00146	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NAMPT—atherosclerosis	0.000975	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOC3—atherosclerosis	0.000963	0.00143	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL4—atherosclerosis	0.000958	0.00143	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—LDLR—atherosclerosis	0.000957	0.00143	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000951	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PLA2G1B—atherosclerosis	0.000942	0.0014	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000932	0.00139	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HSPA1B—atherosclerosis	0.000924	0.00138	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000923	0.00138	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000921	0.00137	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALOX5—atherosclerosis	0.00091	0.00136	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOA2—atherosclerosis	0.000895	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NCF1—atherosclerosis	0.000895	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—UTS2—atherosclerosis	0.000854	0.00127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CYBA—atherosclerosis	0.000842	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000841	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PARP1—atherosclerosis	0.000824	0.00123	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CX3CR1—atherosclerosis	0.000819	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASR—atherosclerosis	0.000819	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NAMPT—atherosclerosis	0.000816	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000812	0.00121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LIPC—atherosclerosis	0.000811	0.00121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOC3—atherosclerosis	0.000806	0.0012	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CX3CL1—atherosclerosis	0.000803	0.0012	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LDLR—atherosclerosis	0.000801	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CETP—atherosclerosis	0.000783	0.00117	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CNR2—atherosclerosis	0.000761	0.00113	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SCARB1—atherosclerosis	0.00075	0.00112	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.00073	0.00109	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HMGCR—atherosclerosis	0.000708	0.00105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VWF—atherosclerosis	0.000678	0.00101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOC3—atherosclerosis	0.000674	0.001	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LDLR—atherosclerosis	0.00067	0.000998	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL3—atherosclerosis	0.000655	0.000975	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000639	0.000951	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCA1—atherosclerosis	0.000631	0.00094	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NCF1—atherosclerosis	0.000627	0.000934	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOB—atherosclerosis	0.000619	0.000922	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EDNRA—atherosclerosis	0.000592	0.000882	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR2—atherosclerosis	0.000592	0.000882	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—LPL—atherosclerosis	0.000591	0.000881	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CYBA—atherosclerosis	0.000589	0.000878	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PARP1—atherosclerosis	0.000577	0.000859	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GHRL—atherosclerosis	0.000577	0.000859	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLAT—atherosclerosis	0.000577	0.000859	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PRKCG—atherosclerosis	0.000575	0.000856	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HMOX1—atherosclerosis	0.000541	0.000807	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTHFR—atherosclerosis	0.000532	0.000793	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOB—atherosclerosis	0.000519	0.000773	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PDGFB—atherosclerosis	0.000518	0.000772	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KNG1—atherosclerosis	0.000506	0.000754	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTM1—atherosclerosis	0.000504	0.000752	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGTR1—atherosclerosis	0.000503	0.00075	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOE—atherosclerosis	0.000496	0.000738	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LPL—atherosclerosis	0.000495	0.000738	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CAV1—atherosclerosis	0.000491	0.000732	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLG—atherosclerosis	0.00049	0.000731	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOA1—atherosclerosis	0.00049	0.00073	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPX1—atherosclerosis	0.000483	0.00072	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CD36—atherosclerosis	0.00047	0.000701	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SOCS3—atherosclerosis	0.000464	0.000692	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS2—atherosclerosis	0.000462	0.000688	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP3—atherosclerosis	0.000449	0.000668	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF2—atherosclerosis	0.000447	0.000665	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTHFR—atherosclerosis	0.000446	0.000664	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARA—atherosclerosis	0.000437	0.000652	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOB—atherosclerosis	0.000434	0.000646	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EDN1—atherosclerosis	0.000427	0.000636	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AGT—atherosclerosis	0.000424	0.000631	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL5—atherosclerosis	0.000423	0.000631	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—INS—atherosclerosis	0.000423	0.000631	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOE—atherosclerosis	0.000415	0.000618	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LPL—atherosclerosis	0.000414	0.000617	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CAV1—atherosclerosis	0.000411	0.000613	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOA1—atherosclerosis	0.00041	0.000611	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCG—atherosclerosis	0.000403	0.0006	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SPP1—atherosclerosis	0.000392	0.000584	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SERPINE1—atherosclerosis	0.000389	0.000579	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CG—atherosclerosis	0.000375	0.000558	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS3—atherosclerosis	0.000371	0.000553	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDGFB—atherosclerosis	0.000363	0.000541	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARG—atherosclerosis	0.000361	0.000539	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—INS—atherosclerosis	0.000355	0.000528	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGT—atherosclerosis	0.000354	0.000528	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEP—atherosclerosis	0.000347	0.000517	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOE—atherosclerosis	0.000347	0.000517	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CAV1—atherosclerosis	0.000344	0.000512	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOA1—atherosclerosis	0.000343	0.000511	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTGS2—atherosclerosis	0.00034	0.000506	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ESR1—atherosclerosis	0.000331	0.000494	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—F2—atherosclerosis	0.000327	0.000488	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALB—atherosclerosis	0.000325	0.000484	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CG—atherosclerosis	0.000313	0.000467	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NOS3—atherosclerosis	0.000311	0.000463	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—INS—atherosclerosis	0.000296	0.000442	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL2—atherosclerosis	0.000292	0.000435	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1—atherosclerosis	0.000287	0.000427	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS2—atherosclerosis	0.000284	0.000424	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SERPINE1—atherosclerosis	0.000272	0.000406	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT3—atherosclerosis	0.000265	0.000395	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOS3—atherosclerosis	0.00026	0.000387	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MAPK3—atherosclerosis	0.000253	0.000377	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFB1—atherosclerosis	0.000245	0.000366	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL8—atherosclerosis	0.000231	0.000344	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—atherosclerosis	0.000209	0.000311	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NFKB1—atherosclerosis	0.000206	0.000307	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK8—atherosclerosis	0.000203	0.000302	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—atherosclerosis	0.000187	0.000279	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT3—atherosclerosis	0.000185	0.000276	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—atherosclerosis	0.000185	0.000276	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK3—atherosclerosis	0.000177	0.000264	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFB1—atherosclerosis	0.000172	0.000256	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—atherosclerosis	0.000171	0.000254	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—atherosclerosis	0.000143	0.000213	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—atherosclerosis	0.00013	0.000193	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—atherosclerosis	0.00012	0.000178	CbGpPWpGaD
